35
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Borna Disease Virus

, &
Pages 259-273 | Published online: 10 Jul 2009

References

  • Altshuler LL, Conrad A, Kovelman JA, Scheibel A (1987). Hippocampal pyramidal cell orientation in schizophrenia: a controlled neurohistologic study of the Yakovlev Collection. Arch Gen Psychiatry 44: 1094–1098.
  • Amsterdam J, Winokur A, Dyson W, Herzog S, Gonzalez F, Rott R, Koprowski H (1985). Borna disease virus: a possible etiologic factor in human affective disorders. Arch Gen Psychiatry 42: 1093–1096.
  • Anderson GM (1994). Studies on the neurochemistry of autism. In: The neurobiology of autism. Bauman ML, Kemper TL (eds). Baltimore: Johns Hopkins University Press, pp 227–242.
  • Bachmann S, Caplazi P, Fischer M, Ehrensperger F, Cone RW (1999). Lack of association between Borna disease virus infection and neurological disorders among HIV-infected individuals. J NeuroVirol 5: 190–195.
  • Bahmani MK, Nowrouzian I, Nakaya T, Nakamura Y, Hagiwara K, Takahashi H, Rad MA, Ikuta K (1996). Var-ied prevalence of Borna disease virus infection in Ara-bic, thoroughbred and their cross-bred horses in Iran. Virus Res 45: 1–13.
  • Bajramovic JJ, Syan S, Brahic M, de la Torre JC, Gonzalez-Dunia D (2002). 1-beta-o-Arabinofuranosylcytosine in-hibits borna disease virus replication and spread. J Virol 76: 6268–6276.
  • Bautista JR, Rubin SA, Moran TH, Schwartz GJ, Carbone KM (1995). Developmental injury to the cerebellum fol-lowing perinatal Borna disease virus infection. Brain Res Dev Brain Res 90: 45–53.
  • Bautista JR, Schwartz GJ, de la Torre JC, Moran TH, Carbone KM (1994). Early and persistent abnormalities in rats with neonatally acquired Borna disease virus infection. Brain Res Bull 34: 31–40.
  • Berg M, Ehrenborg C, Blomberg J, Pipkom R, Berg AL (1998). Two domains of the Borna disease virus p40 pro-tein are required for interaction with the p23 protein. J Gen Virol 79: 2957–2963.
  • Berg M, Johansson M, Montell H, Berg AL (2001). Wild birds as a possible natural reservoir of Borna disease virus. Epidemio/ Infect 127: 173–178.
  • Binz T, Lebelt J, Niemann H, Hagenau K (1994). Sequence analyses of the p24 gene of Boma disease virus in nat-urally infected horse, donkey and sheep. Virus Res 34: 281–289.
  • Bode L, Dietrich DE, Stoyloff R, Emrich HM, Ludwig H (1997). Amantadine and human Boma disease virus in vitro and in vivo in an infected patient with bipolar de-pression [letter] [see comments]. Lancet 349: 178–179.
  • Bode L, Diirrwald R, Rantam FA, Ferszt R, Ludwig H (1996). First isolates of infectious human Borna disease virus from patients with mood disorders. Mol Psychiatry 1: 200–212.
  • Bode L, Ferszt R, Czech G (1993). Boma disease virus in-fection and affective disorders in man. Arch Virol Suppl 7: 159–167.
  • Bode L, Reckwald P, Severus WE, Stoyloff R, Ferszt R, Dietrich DE, Ludwig H (2001). Borna disease virus-specific circulating immune complexes, antigenemia, and free antibodies-the key marker triplet determin-ing infection and prevailing in severe mood disorders. Mo/ Psychiatry 6: 481–491.
  • Bode L, Riegel S, Lange W, Ludwig H (1992). Human infec-tions with Borna disease virus: seroprevalence in pa-tients with chronic diseases and healthy individuals. J Med Virol 36: 309–315.
  • Bode L, Riegel S, Ludwig H, Amsterdam JD, Lange W, Koprowski H (1988). Borna disease virus-specific antibodies in patients with HIV infection and with men-tal disorders [letter]. Lancet 2: 689.
  • Bode L, Zimmermann W, Ferszt R, Steinbach F, Ludwig H (1995). Borna disease virus genome transcribed and expressed in psychiatric patients. Nat Med 1: 232–236.
  • Briese T, de la Torre JC, Lewis A, Ludwig H, Lipkin WI (1992). Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc Nail Acad Sci US A 89: 11486–11489.
  • Briese T, Schneemann A, Lewis AJ, Park YS, Kim S, Ludwig H, Lipkin WI (1994). Genomic organization of Borna dis-ease virus. Proc Nail Acad Sci US A 91: 4362–4366.
  • Caplazi P, Waldvogel A, Stitz L, Braun U, Ehrensperger F (1994). Boma disease in naturally infected cattle. J Comp Pathal 111: 62–72.
  • Carbone KM, Duchala CS, Griffin JW, Kincaid AL, Narayan 0 (1987). Pathogenesis of Borna disease in rats: evidence that intra-axonal spread is the major route for virus dis-semination and the determinant for disease incubation. J Virol 61: 3431–3440.
  • Carbone KM, Moench TR, Lipkin WI (1991a). Borna dis-ease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridiza-tion. J Neuropathol Exp Neurol 50: 205–214.
  • Carbone KM, Park SW, Rubin SA, Waltrip RW 2nd, Vogelsang GB (1991b). Boma disease: association with a maturation defect in the cellular immune response. J Virol 65: 6154–6164.
  • Chen CH, Chiu YL, Shaw CK, Tsai MT, Hwang AL, Hsiao KJ (1999a). Detection of Borna disease virus RNA from pe-ripheral blood cells in schizophrenic patients and men-tal health workers. Mo/ Psychiatry 4: 566–571.
  • Chen CH, Chiu YL, Wei FC, Koong FJ, Liu HC, Shaw CK, Hwu HG, Hsiao KJ (1999b). High seroprevalence of Borna virus infection in schizophrenic patients, family members and mental health workers in Taiwan [In Pro-cess Citation]. Mo/ Psychiatry 4: 33–38.
  • Cooper JR, Bloom FE, Roth RH (1991). The biochemical ba-sis of neuropharmacology. New York: Oxford University Press.
  • Cubitt B, de la Torre JC (1994). Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present. J Virol 68: 1371–1381.
  • Cubitt B, de la Torre JC (1997). Amantadine does not have antiviral activity against Borna disease virus. Arch Virol 142: 2035–2042.
  • Cubitt B, Ly C, de la Torre JC (2001). Identification and characterization of a new intron in Boma disease virus. J Gen Virol 82: 641–646.
  • Cubitt B, Oldstone C, Valcarcel J, Carlos de la Torre J (1994). RNA splicing contributes to the generation of mature mRNAs of Boma disease virus, a non-segmented nega-tive strand RNA virus. Virus Res 34: 69–79.
  • Czygan M, Hallensleben W, Hofer M, Pollak S, Sauder C, Bilzer T, Blumcke I, Riederer P, Bogerts B, Falkai P, Schwarz MJ, Masliah E, Staeheli P, Hufert FT, Lieb K (1999). Boma disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders. /Infect Dis 180: 1695–1699.
  • Dauphin G, Legay V, Sailleau C, Smondack S, Ha=oumi S, Zientara S (2001). Evidence of Borna disease virus genome detection in French domestic animals and in foxes (Vulpes vulpes). J Gen Virol 82: 2199–2204.
  • de la Torre JC, Bode L, Durrwald R, Cubitt B, Ludwig H (1996). Sequence characterization of human Borna dis-ease virus. Virus Res 44: 33–44.
  • Degiorgis MP, Berg AL, Hard Af Segerstad C, Morner T, Johansson M, Berg M (2000). Borna disease in a free-ranging lynx (Lynx lynx). J Clin Microbic)] 38: 3087–3091.
  • Deuschle M, Bode L, Heuser I, Schmider J, Ludwig H (1998). Borna disease virus proteins in cerebrospinal fluid of patients with recurrent depression and multi-ple sclerosis [letter]. Lancet 352: 1828–1829.
  • Dietrich DE, Bode L, Spannhuth CW, Lau T, Huber TJ, Brodhun B, Ludwig H, Emrich HM (2000). Amantadine in depressive patients with Boma disease virus (BDV) infection: an open trial. Bipolar Disord 2: 65–70.
  • Dittrich W, Bode L, Ludwig H, Kao M, Schneider K (1989). Learning deficiencies in Borna disease virus-infected but clinically healthy rats. Biol Psychiatry 26: 818–828.
  • Eisenman LM, Brother R, Tran MH, Kean RB, Dickson GM, Dietzschold B, Hooper DC (1999). Neonatal Boma dis-ease virus infection in the rat causes a loss of Purkinje cells in the cerebellum. J NeuroVirol 5: 181–189.
  • Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM (1997). Low medial prefrontal dopaminergic activity in autistic children. Lancet 350: 638.
  • Evengard B, Briese T, Lindh G, Lee S, Lipkin WI (1999). Absence of evidence of Borna disease virus infection in Swedish patients with chronic fatigue syndrome. J NeuroVirol 5: 495–499.
  • Ferszt R, Kuhl KP, Bode L, Severus EW, Winzer B, Berghofer A, Beelitz G, Brodhun B, Muller-Oerlinghausen B, Ludwig H (1999). Amantadine revisited: an open trial of amantadinesulfate treatment in chronically depressed patients with Borna disease virus infection. Pharma-copsychiatry 32: 142–147.
  • Fish B, Marcus J, Hans SL, Auerbach JG, Perdue S (1992). Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect: a review and replication analy-sis of pandysmaturation in the Jerusalem Infant Devel-opment Study. Arch Gen Psychiatry 49: 221–235.
  • Fu ZF, Amsterdam JD, Kao M, Shankar V, Koprowski H, Dietzschold B (1993a). Detection of Borna disease virus-reactive antibodies from patients with affective disor-ders by western i=unoblot technique. J Affect Disor-ders 27: 61–68.
  • Fu ZF, Weihe E, Zheng YM, Schafer MK, Sheng H, Corisdeo S, Rauscher FJI, Koprowski H, Dietzschold B (1993b). Differential effects of rabies and borna disease viruses on immediate-, early-, and late-response gene expression in brain tissues. J Virol 67: 6674–6681.
  • Fukuda K, Takahashi K, Iwata Y, Mori N, Gonda K, Ogawa T, Osonoe K, Sato M, Ogata S, Horimoto T, Sawada T, Tashiro M, Yamaguchi K, Niwa S, Shigeta S (2001). Im-munological and PCR analyses for Boma disease virus in psychiatric patients and blood donors in Japan. J Clin Microbiol 39: 419–429.
  • Furrer E, Bilzer T, Stitz L, Planz 0 (2001). Neutralizing an-tibodies in persistent borna disease virus infection: pro-phylactic effect of gp94-specific monoclonal antibodies in preventing encephalitis. J Virol 75: 943–951.
  • Galabru J, Saron MF, Berg M, Berg AL, Herzog S, LabieJ, Zientara S (2000). Borna disease virus antibodies in French horses. Vet Rec 147: 721–722.
  • Gies U, Bilzer T, Stitz L, Staiger JF (1998). Disturbance of the cortical cholinergic innervation in Borna disease prior to encephalitis. Brain Pathol 8: 39–48.
  • Gonzalez-Dunia D, Cubitt B, de la Torre JC (1998). Mecha-nism of Borna disease virus entry into cells. J Virol 72: 783–788.
  • Gonzalez-Dunia D, Cubitt B, Grasser FA, de la Torre JC (1997). Characterization of Boma disease virus p56 pro-tein, a surface glycoprotein involved in virus entry. J Virol 71: 3208–3218.
  • Gosztonyi G, Ludwig H (2001). Interactions of viral proteins with neurotransmitter receptors may protect or destroy neurons. Curr Top Microbiol Immunol 253: 121–144.
  • Haase CG, Viazov S, Fiedler M, Koenig N, Faustrnann PM, Roggendorf M (2001). Borna disease virus RNA is absent in chronic multiple sclerosis. Ann Neurol 50: 423–424.
  • Haga S, Yoshimura M, Motoi Y, Arima K, Aizawa T, Ikuta K, Tashiro M, Ikeda K (1997). Detection of Borna disease virus genome in normal human brain tissue. Brain Res 770: 307–309.
  • Hagiwara K, Asakawa M, Liao L, Jiang W, Yan S, Chai J, Oku Y, Ikuta K, Ito M (2001). Seroprevalence of Boma disease virus in domestic animals in Xinjiang, China. Vet Microbiol 80: 383–389.
  • Hagiwara K, Kamitani W, Takamura S, Taniyama H, Nakaya T, Tanaka H, Kirisawa R, Iwai H, Ikuta K (2000). Detec-tion of Borna disease virus in a pregnant mare and her fetus. Vet Microbiol 72: 207–216.
  • Hagiwara K, Kawamoto S, Takahashi H, Nakamura Y, Nakaya T, Hiramune T, Ishihara C, Ikuta K (1997a). High prevalence of Boma disease virus infection in healthy sheep in Japan. Clin Diagn Lab Immunol 4: 339–344.
  • Hagiwara K, Momiyama N, Taniyama H, Nakaya T, Tsunoda N, Ishihara C, Ikuta K (1997b). Demonstration of Boma disease virus (BDV) in specific regions of the brain from horses positive for serum antibodies to BDV but nega-tive for BDV RNA in the blood and internal organs. Med Microbiol Immunol (Bed) 186: 19–24.
  • Hagiwara K, Nakaya T, Nakamura Y, Asahi S, Takahashi H, Ishihara C, Ikuta K (1996). Boma disease virus RNA in peripheral blood mononuclear cells obtained from healthy dairy cattle. Med Microbiol Immunol (Bed) 185: 145–151.
  • Hallensleben W, Zocher M, Staeheli P (1997). Borna dis-ease virus is not sensitive to amantadine. Arch Viro1142: 2043–2048.
  • Hamner MB, Diamond BI (1996). Plasma dopamine and norepinephrine correlations with psychomotor retar-dation, anxiety, and depression in non-psychotic de-pressed patients: a pilot study. Psychiatry Res 64: 209–211.
  • Hans A, Syan S, Crosio C, Sassone-Corsi P, Brahic M, Gonzalez-Dunia D (2001). Borna disease virus persis-tent infection activates mitogen- activated protein kinase and blocks neuronal differentiation of PC12 cells. J Biol Chem 276: 7258–7265.
  • Hatalski CG (1996). Alterations in the immune response within the central nervous system of rats infected with Borna disease virus: potential mechanisms for viral per-sistence. PhD Thesis, University of California Irvine, Irvine, CA.
  • Hatalski CG, Hickey WF, Lipkin WI (1998). Evolution of the immune response in the central nervous system follow-ing infection with Borna disease virus. J Neuroimmunol 90: 137–142.
  • Hatalski CG, Kliche S, Stitz L, Lipkin WI (1995). Neutral-izing antibodies in Borna disease virus-infected rats. J Virol 69: 741–747.
  • Hatalski CG, Lewis AJ, Lipkin WI (1997). Borna disease. Em erg Infect Dis 3: 129–135.
  • Helps CR, Turan N, Bilal T, Harbour DA, Yilmaz H (2001). Detection of antibodies to Boma disease virus in Turkish cats by using recombinant p40. Vet Rec 149: 647–650.
  • Hirano N, Kao M, Ludwig H (1983). Persistent, tolerant or subacute infection in Boma disease virus-infected rats. J Gen Virol 64: 1521–1530.
  • Horii Y, Garcia NP, Noviana D, Kono F, Sawada T, Naraki T, Yamaguchi K (2001). Detection of anti-boma disease virus antibodies from cats in Asian countries, Japan, Philippines and Indonesia using electrochemilumines-cence immunoassay. J Vet Med Sci 63: 921–923.
  • Hornig M, Briese T, Lipkin WI (2001). Bomavirus tropism and targeted pathogenesis: virus-host interactions in a neurodevelopmental model. A dv Virus Res 56: 557–582.
  • Hornig M, Weissenböck H, Horscroft N, Lipkin WI (1999). An infection-based model of neurodevelopmental dam-age. Proc Nati Acad Sci USA 96: 12102–12107.
  • Igata-Yi R, Yamaguchi K, Yoshiki K, Takemoto S, Yamasaki H, Matsuoka M, Miyakawa T (1996). Boma disease virus and the consumption of raw horse meat [letter]. Nat Med 2: 948–949.
  • Iwahashi K, Watanabe M, Nakamura K, Suwaki H, Nakaya T, Nakamura Y, Takahashi H, Ikuta K (1997). Clinical investigation of the relationship between Borna disease virus (BDV) infection and schizophrenia in 67 patients in Japan. Acta Psychiatr Scand 96: 412–415.
  • Iwata Y, Takahashi K, Peng X, Fukuda K, Ohno K, Ogawa T, Gonda K, Mori N, Niwa S, Shigeta 5 (1998). Detectionand sequence analysis of borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors. J Virol 72: 10044–10049.
  • Kamitani W, Shoya Y, Kobayashi T, Watanabe M, Lee BJ, Zhang G, Tomonaga K, Ikuta K (2001). Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1. J Virol 75: 8742–8751.
  • Kane J, Marder J (1993). Psychopharmacologic treatments of schizophrenia. Schizophr Bull 19: 287–302.
  • Kao M, Hamir AN, Rupprecht CE, Fu ZF, Shankar V, Koprowski H, Dietzschold B (1993). Detection of an-tibodies against Boma disease virus in sera and cere-brospinal fluid of horses in the USA. Vet Rec 132: 241–244.
  • Kao M, Ludwig H, Gosztonyi G (1984). Adaptation of Borna disease virus to the mouse. J Gen Virol 65: 1845–1849.
  • Karpas WJ, Peterson JD, Miller SD (1994). Anergy in vivo: downregulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses. Int Immunol 6: 721–730.
  • Kelsoe JR, Savodnick AD, Kristbjamarson H, Bergesch P, Mroczkowski-Parker Z, Drennan M, Rapaport MH, Flodman P, Spence MA, Remick RA (1996). Possible lo-cus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 67: 533–540.
  • Kemper TL, Bauman ML (1993). The contribution of neu-ropathologic studies to the understanding of autism. Neurol Clin North Am 11: 175–187.
  • Khoury SJ, Akalin E, Chandraker A, Turka LA, Linsley PS, Sayegh MH, Hancock WW (1995). CD28-B7 costimula-tory blockade by CTLA4Ig prevents actively induced ex-perimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous sys-tem. J Immuno1155: 4521–4524.
  • Kiermayer S, Kraus I, Richt JA, Garten W, Eickmann M (2002). Identification of the amino terminal subunit of the glycoprotein of Borna disease virus. FEBS Lett 531: 255–258.
  • Kilbourne ED (1991). New viruses and new disease: muta-tion, evolution and ecology. Curr Opin Immunol 3: 518–524.
  • Kim YK, Kim SH, Choi SH, Ko YH, Kim L, Lee MS, Suh KY, Kwak DI, Song KJ, Lee YJ, Yanagihara R, Song JW (1999). Failure to demonstrate Boma disease virus genome in peripheral blood mononuclear cells from psychiatric pa-tients in Korea. J NeuroVirol 5: 196–199.
  • Kishi M, Arimura Y, Ikuta K, Shoya Y, Lai PK, Kakinuma M (1996). Sequence variability of Borna disease virus open reading frame II found in human peripheral blood mononuclear cells. J Virol 70: 635–640.
  • Kishi M, Nakaya T, Nakamura Y, Kakinuma M, Takahashi TA, Sekiguchi S, Uchikawa M, Tadokoro K, Ikeda K, Ikuta K (1995a). Prevalence of Borna disease virus RNA in peripheral blood mononuclear cells from blood donors. Med Microbiol Immunol (Berl) 184: 135–138.
  • Kishi M, Nakaya T, Nakamura Y, Zhong Q, Ikeda K, Senjo M, Kakinuma M, Kato S, Ikuta K (1995b). Demonstration of human Boma disease virus RNA in human peripheral blood mononuclear cells. FEBS Lett 364: 293–297.
  • Kitani T, Kuratsune H, Fuke I, Nakamura Y, Nakaya T, Asahi S, Tobiume M, Yamaguti K, Machii T, Inagi R, Yamanishi K, Ikuta K (1996). Possible correlation be-tween Borna disease virus infection and Japanese patients with chronic fatigue syndrome. Microbiol Immunol 40: 459–462.
  • Kitze B, Herzog S, Rieckmann P, Poser S, Richt J (1996). No evidence of Borna disease virus-specific antibodies in multiple sclerosis patients in Germany [letter]. J Neurol 243: 660–662.
  • Kobayashi T, Kamitani W, Zhang G, Watanabe M, Tomonaga K, Ikuta K (2001). Boma disease virus nucleoprotein re-quires both nuclear localization and export activities for viral nucleocytoplasmic shuttling. J Virol 75: 3404–34012.
  • Kobayashi T, Shoya Y, Koda T, Takashima I, Lai PK, Ikuta K, Kakinuma M, Kishi M (1998). Nuclear targeting activity associated with the amino terminal region of the Borna disease virus nucleoprotein. Virology 243: 188–197.
  • Konradi C, Kobierski LA, Nguyen TV, Heckers S, Hyman SE (1993). The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc Nail Acad Sci USA 90: 7005–7009.
  • Kubo K, Fujiyoshi T, Yokoyama MM, Kamei K, Richt JA, Kitze B, Herzog S, Takigawa M, Sonoda S (1997). Lack of association of Borna disease virus and human T-cell leukemia virus type 1 infections with psychiatric disor-ders among Japanese patients. Clin Diagn Lab Immunol 4: 189–194.
  • Lebain P, Vabret A, Freymuth F, Brazo P, Chabot B, Dollfus S, Henri B (2002). Borna disease virus and psychiatric disorders. Schizophr Res 57: 303–305.
  • Lieb K, Hallensleben W, Czygan M, Stitz L, Staeheli P (1997). No Borna disease virus-specific RNA detected in blood from psychiatric patients in different regions of Germany. The Bomavirus Study Group [letter]. Lancet 350: 1002.
  • Lipkin WI, Carbone KM, Wilson MC, Duchala CS, Narayan O, Oldstone MB (1988). Neurotransmitter abnormalities in Borna disease. Brain Res 475: 366–370.
  • Lipkin WI, Hornig M, Briese T (2001). Borna disease virus and neuropsychiatric disease-a reappraisal. Trends Mi-crobiol 9: 295–298.
  • Lipkin WI, Travis GH, Carbone KM, Wilson MC (1990). Iso-lation and characterization of Borna disease agent cDNA clones. Proc Nail Acad Sci US A 87: 4184–4188.
  • Ludwig H, Bode L, Gosztonyi G (1988). Borna disease: a persistent virus infection of the central nervous system. Prog Med Virol 35: 107–151.
  • Lundgren AL, Czech G, Bode L, Ludwig H (1993). Natural Borna disease in domestic animals others than horses and sheep. Zentralbl Veterinarmed [R]40: 298–303.
  • Malkinson M, Weisman Y, Ashash E, Bode L, Ludwig H (1993). Boma disease in ostriches [letter; comment]. Vet Rec 133: 304.
  • Nakamura Y, Asahi S, Nakaya T, Bahmani MK, Saitoh S, Yasui K, Mayama H, Hagiwara K, Ishihara C, Ikuta K (1996). Demonstration of boma disease virus RNA in pe-ripheral blood mononuclear cells derived from domestic cats in Japan. J Clin Microbiol 34: 188–191.
  • Nakamura Y, Kishi M, Nakaya T, Asahi S, Tanaka H, Sentsui H, Ikeda K, Ikuta K (1995). Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells from healthy horses in Japan. Vaccine 13: 1076–1079.
  • Nakamura Y, Takahashi H, Shoya Y, Nakaya T, Watanabe M, Tomonaga K, Iwahashi K, Ameno K, Momiyama N, Taniyama H, Sata T, Kurata T, de la Torre JC, Ikuta K (2000). Isolation of Borna disease virus from human brain tissue. J Virol 74: 4601–4611.
  • Nakamura Y, Watanabe M, Kamitani W, Taniyama H, Nakaya T, Nishimura Y, Tsujimoto H, Machida S, Ikuta K (1999). High prevalence of Borna disease virus in do-mestic cats with neurological disorders in Japan. Vet Microbiol 70: 153–169.
  • Nakaya T, Kuratsune H, Kitani T, Ikuta K (1997). [Demon-stration on Boma disease virus in patients with chronic fatigue syndrome] . Nippon Rinsho 55: 3064–3071.
  • Nakaya T, Takahashi H, Nakamura Y, Asahi S, Tobiume M, Kuratsune H, Kitani T, Yamanishi K, Ikuta K (1996). Demonstration of Boma disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome. FEBS Lett 378: 145–149.
  • Nakaya T, Takahashi H, Nakamura Y, Kuratsune H, Kitani T, Machii T, Yamanishi K, Ikuta K (1999). Borna disease virus infection in two family clusters of patients with chronic fatigue syndrome. Microbiol Immunol 43: 679–689.
  • Narayan O, Herzog S, Frese K, Scheefers H, Rott R (1983). Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities. J Infect Dis 148: 305–315.
  • Nishino Y, Kobasa D, Rubin SA, Pletnikov MV, Carbone KM (2002). Enhanced neurovirulence of borna disease virus variants associated with nucleotide changes in the glycoprotein and L polymerase genes. J Virol 76: 8650–8658.
  • Nowotny N, Kolodziejek J, Jehle CO, Suchy A, Staeheli P, Schwe=le M (2000). Isolation and characterization of a new subtype of Borna disease virus. J Virol 74: 5655–5658.
  • Okamoto M, Kagawa Y, Kamitani W, Hagiwara K, Kirisawa R, Iwai H, Ikuta K, Taniyama H (2002). Boma disease in a dog in Japan. J Comp Pathol 126: 312–317.
  • Partonen T (1996). Dopamine and circadian rhythms in sea-sonal affective disorder. Med Hyp 47: 191–192.
  • Perez M, Watanabe M, Whitt MA, de la Torre JC (2001). N-terminal domain of Boma disease virus G (p56) pro-tein is sufficient for virus receptor recognition and cell entry. J Virol 75: 7078–7085.
  • Planz O, Pleschka S, Ludwig S (2001). MEK-specific in-hibitor U0126 blocks spread of Borna disease virus in cultured cells. J Virol 75: 4871–4877.
  • Planz O, Rentzsch C, Batra A, Rziha HJ, Stitz L (1998). Persistence of Borna disease virus-specific nucleic acid in blood of psychiatric patient [letter]. Lancet 352: 623.
  • Planz O, Rentzsch C, Batra A, Winkler T, Buttner M, Rziha HJ, Stitz L (1999). Pathogenesis of borna disease virus: granulocyte fractions of psychiatric patients harbor in-fectious virus in the absence of antiviral antibodies. J Virol 73: 6251–6256.
  • Pleschka S, Staeheli P, Kolodziejek J, Richt JA, Nowotny N, Schwe=le M (2001). Conservation of coding poten-tial and terminal sequences in four different isolates of Borna disease virus. J Gen Virol 82: 2681–2690.
  • Pletnikov MV, Rubin SA, Carbone KM, Moran TH, Schwartz GJ (2001). Neonatal Boma disease virus in-fection (BDV)-induced damage to the cerebellum is as-sociated with sensorimotor deficits in developing Lewis rats. Brain Res Dev Brain Res 126: 1–12.
  • Pletnikov MV, Rubin SA, Schwartz GJ, Moran TH, Sobotka TJ, Carbone KM (1999a). Persistent neonatal Boma dis-ease virus (BDV) infection of the brain causes chronicemotional abnormalities in adult rats. Physiol Behav 66: 823–831.
  • Pletnikov MV, Rubin SA, Vasudevan K, Moran TH, Carbone KM (1999b). Developmental brain injury associated with abnormal play behavior in neonatally Boma disease virus-infected Lewis rats: a model of autism. Behav Brain Res 100: 43–50.
  • Pyper JM, Gartner AE (1997). Molecular basis for the dif-ferential subcellular localization of the 38- and 39-kilodalton structural proteins of Boma disease virus. J Virol 71: 5133–5139.
  • Rauer M, Pagenstecher A, Schulte-Monting J, Sauder C (2002). Upregulation of chemokine receptor gene ex-pression in brains of Borna disease virus (BDV)-infected rats in the absence and presence of inflammation. J NeuroVirol 8: 168–179.
  • Reeves NA, Helps CR, Gunn-Moore DA, Blundell C, Finnemore PL, Pearson GR, Harbour DA (1998). Natu-ral Boma disease virus infection in cats in the United Kingdom [In Process Citation]. Vet Rec 143: 523–526.
  • Richt JA, Alexander RC, Herzog S, Hooper DC, Kean R, Spitsin S, Bechter K, Schuttler R, Feldmann H, Heiske A, Fu ZF, Dietzschold B, Rott R, Koprowski H (1997). Fail-ure to detect Boma disease virus infection in peripheral blood leukocytes from humans with psychiatric disor-ders. J NeuroVirol 3: 174–178.
  • Richt JA, Furbringer T, Koch A, Pfeuffer I, Herden C, Bause-Niedrig I, Garten W (1998). Processing of the Boma dis-ease virus glycoprotein gp94 by the subtilisin-like endo-protease furin. J Virol 72: 4528–4533.
  • Rott R, Herzog S, Bechter K, Frese K (1991). Borna disease, a possible hazard for man. Arch Virol 118: 143–149.
  • Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, Dyson W, Koprowski H (1985). Detection of serum an-tibodies to Boma disease virus in patients with psychi-atric disorders. Science 228: 755–756.
  • Rubin SA, Sierra-Honigmann AM, Lederman HM, Waltrip RW 2nd, Eiden JJ, Carbone KM (1995). Hematologic consequences of Borna disease virus infection of rat bone marrow and thymus stromal cells. Blood 85: 2762–2769.
  • Rubin SA, Sylves P, Vogel M, Pletnikov M, Moran TH, Schwartz GJ, Carbone KM (1999). Borna disease virus-induced hippocampal dentate gyrus damage is associ-ated with spatial learning and memory deficits. Brain Res Bull 48: 23–30.
  • Rybakowski F, Sawada T, Yamaguchi K (2001a). Borna dis-ease virus-reactive antibodies and recent-onset psychi-atric disorders. Eur Psychiatry 16: 191–192.
  • Rybakowski F, Sawada T, Yamaguchi K, Rajewski A, Rybakowski J (2002). Boma disease virus-reactive an-tibodies in Polish psychiatric patients. Med Sci Monit 8: CR642-CR646.
  • Rybakowski F, Yamaguchi K, Krzyminski S, Zmyslony F, Biemat J, Kocialkowski M, Tandeck A, Trafarska B, Zalejski M, Sawada T, Naraki T, Czerski P, Rajewski A, Rybakowski JK (2001b). [Detection of anti-Boma disease virus antibodies in patients hospitalized in psychiatric hospitals located in the mid-Western region of Poland]. Psychiatr Pol 35: 819–829.
  • Salvatore M, Morzunov S, Schwemmle M, Lipkin WI (1997). Boma disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Bornavirus Study Group [letter]. Lancet 349: 1813–1814.
  • Sauder C, de la Torre JC (1999). Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection. J Neuroimmunol 96: 29–45.
  • Sauder C, Hallensleben W, Pagenstecher A, Schnecken-burger S, Biro L, Pertlik D, Hausmann J, Suter M, Staeheli P (2000). Chemokine gene expression in astro-cytes of Boma disease virus-infected rats and mice in the absence of inflammation. J Virol 74: 9267–9280.
  • Sauder C, Muller A, Cubitt B, Mayer J, Steinmetz J, Trabert W, Ziegler B, Wanke K, Mueller-Lantzsch N, de la Torre JC, Grasser FA (1996). Detection of Boma dis-ease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of hu-man blood-derived BDV RNA. J Virol 70: 7713–7724.
  • Schneemann A, Schneider PA, Kim S, Lipkin WI (1994). Identification of signal sequences that control transcrip-tion of borna disease virus, a nonsegmented, negative-strand RNA virus. J Virol 68: 6514–6522.
  • Schneemann A, Schneider PA, Lamb RA, Lipkin WI (1995). The remarkable coding strategy of borna disease virus: a new member of the nonsegmented negative strand RNA viruses. Virology 210: 1–8.
  • Schneider PA, Briese T, Zimmermann W, Ludwig H, Lipkin WI (1994a). Sequence conservation in field and experimental isolates of Boma disease virus. J Virol 68: 63–68.
  • Schneider PA, Hatalski CG, Lewis AJ, Lipkin WI (1997a). Biochemical and functional analysis of the Boma dis-ease virus G protein. J Virol 71: 331–336.
  • Schneider PA, Kim R, Lipkin WI (1997b). Evidence for translation of the Borna disease virus G protein by leaky ribosomal scanning and ribosomal reinitiation. J Virol 71: 5614–5619.
  • Schneider PA, Schneemann A, Lipkin WI (1994b). RNA splicing in Borna disease virus, a nonsegmented, negative-strand RNA virus. J Virol 68: 5007–5012.
  • Schwartz RH (1992). Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B4/BB1 in interleukin-2 pro-duction and immunotherapy. Cell 71: 1065–1068.
  • Schwe=le M (2001). Borna disease virus infection in psy-chiatric patients: are we on the right track? Lancet Infect Dis 1: 46–52.
  • Schwe=le M, De B, Shi L, Banerjee A, Lipkin WI (1997). Boma disease virus P-protein is phosphorylated by pro-tein kinase Cepsilon and casein kinase II. J Biol Chem 272: 21818–21823.
  • Schwe=le M, Jehle C, Formella S, Staeheli P (1999a). Sequence similarities between human bornavirus iso-lates and laboratory strains question human origin. Lancet 354: 1973–1974.
  • Schwe=le M, Jehle C, Shoemaker T, Lipkin WI (1999b). Characterization of the major nuclear localization signal of the Boma disease virus phosphoprotein. J Gen Virol 80: 97–100.
  • Schwe=le M, Salvatore M, Shi L, Richt J, Lee CH, Lipkin WI (1998). Interactions of the borna disease virus P, N, and X proteins and their functional implications. J Biol Chem 273: 9007–9012.
  • Selten JP, van Vliet K, Pleyte W, Herzog S, Hoek HW, van Loon AM (2000). Borna disease virus and schizophre-nia in Surinamese immigrants to the Netherlands. Med Microbic)] Immunol (Berl) 189: 55–57.
  • Shoya Y, Kobayashi T, Koda T, Ikuta K, Kakinuma M, Kishi M (1998). Two proline-rich nuclear localization signals in the amino- and carboxyl-terminal regions of the Borna disease virus phosphoprotein. J Virol 72: 9755–9762.
  • Sierra-Honigmann AM, Carbone KM, Yolken RH (1995). Polymerase chain reaction (PCR) search for viral nucleic acid sequences in schizophrenia. Br J Psychiatry 166: 55–60.
  • Sierra-Honigmann AM, Rubin SA, Estafanous MG, Yolken RH, Carbone KM (1993). Borna disease virus in pe-ripheral blood mononuclear and bone marrow cells of neonatally and chronically infected rats. J Neuroim-munol 45: 31–36.
  • Soares JC, Mann JJ (1997). The anatomy of mood disorders-review of structural neuroimaging studies. Biol Psychiatry 41: 86–106.
  • Sobbe M, Bilzer T, Go=e1 S, Noske K, Planz O, Stitz L (1997). Induction of degenerative brain lesions after adoptive transfer of brain lymphocytes from Boma dis-ease virus-infected rats: presence of CD8+ T cells and perforin mRNA. J Virol 71: 2400–2407.
  • Solbrig MV, Fallon JH, Lipkin WI (1995). Behavioral dis-turbances and pharmacology of Boma disease. Curr Top Microbic)] Immunol 190: 93–101.
  • Solbrig MV, Koob GF, Fallon JH, Lipkin WI (1994). Tardive dyskinetic syndrome in rats infected with Boma disease virus. Neurobiol Dis 1: 111–119.
  • Solbrig MV, Koob GF, Fallon JH, Reid S, Lipkin WI (1996a). Prefrontal cortex dysfunction in Boma disease virus (BDV)-infected rats. Biol Psychiatry 40: 629–636.
  • Solbrig MV, Koob GF, Joyce JN, Lipkin WI (1996b). A neural substrate of hyperactivity in Boma disease: changes in brain dopamine receptors. Virology 222: 332–338.
  • Solbrig MV, Koob GF, Lipkin WI (1998). Cocaine sensi-tivity in Borna disease virus-infected rats. Pharmacol Biochem Behav 59: 1047–1052.
  • Solbrig MV, Koob GF, Lipkin WI (2002). Key role for enkephalinergic tone in cortico-striatal-thalamic func-tion. Eur j Neurosci 16: 1819–1822.
  • Solbrig MV, Koob GF, Parsons LH, Kadota T, Horscroft N, Briese T, Lipkin WI (2000). Neurotrophic factor expres-sion after CNS viral injury produces enhanced sensitiv-ity to psycho stimulants: potential mechanism for addic-tion vulnerability. J Neurosci 20: RC104.
  • Staeheli P, Lieb K (2001). Bomavirus and psychiatric disorders-fact or fiction? J Med Microbic)] 50: 579–581.
  • Stitz L, Noske K, Planz O, Furrer E, Lipkin WI, Bilzer T (1998a). A functional role for neutralizing antibodies in Borna disease: influence on virus tropism outside the central nervous system. J Virol 72: 8884–8892.
  • Stitz L, Planz O, Bilzer T (1998b). Lack of antiviral effect of amantadine in Boma disease virus infection. Med Microbic)] Immunol (Berl) 186: 195–200.
  • Takahashi H, Nakaya T, Nakamura Y, Asahi S, Onishi Y, Ike-buchi K, Takahashi TA, Katoh T, Sekiguchi S, Takazawa M, Tanaka H, Ikuta K (1997). Higher prevalence of Borna disease virus infection in blood donors living near thor-oughbred horse farms. J Med Virol 52: 330–335.
  • Tomonaga K, Kobayashi T, Lee BJ, Watanabe M, Kamitani W, Ikuta K (2000). Identification of alternative splic-ing and negative splicing activity of a nonsegmented negative-strand RNA virus, Borna disease virus. Proc Nail Acad Sci USA 97: 12788–12793.
  • Tsuji K, Toyomasu K, Imamura Y, Maeda H, Toyoda T (2000). No association of borna disease virus with psy-chiatric disorders among patients in northern Kyushu, Japan. J Med Virol 61: 336–340.
  • Tsujimura K, Mizutani T, Kariwa H, Yoshimatsu K, Ogino M, Morii Y, Inagaki H, Arikawa J, Takashima 1(1999). A serosurvey of Boma disease virus infection in wild ratsby a capture ELISA [In Process Citation]. J Vet Med Sci 61: 113–117.
  • Vahlenkamp TW, Enbergs HK, Muller H (2000). Experimen-tal and natural borna disease virus infections: presence of viral RNA in cells of the peripheral blood. Vet Micro-bic)] 76: 229–244.
  • VandeWoude S, Richt J, Zink M, Rott R, Narayan O, Clements J (1990). A Boma virus cDNA encoding a pro-tein recognized by antibodies in humans with behav-ioral diseases. Science 250: 1276–1281.
  • Walker MP, Jordan I, Briese T, Fischer N, Lipkin WI (2000). Expression and characterization of the Borna disease virus polymerase. J Virol 74: 4425–4428.
  • Walker MP, Lipkin WI (2002). Characterization of the nu-clear localization signal of the borna disease virus poly-merase. J Virol 76: 8460–8467.
  • Waltrip RW 2nd, Buchanan RW, Carpenter WT Jr, Kirkpatrick B, Su=erfelt A, Breier A, Rubin SA, Carbone KM (1997). Borna disease virus antibodies and the deficit syndrome of schizophrenia. Schizophr Res 23: 253–257.
  • Waltrip RW 2nd, Buchanan RW, Summerfelt A, Breier A, Carpenter WT Jr, Bryant NL, Rubin SA, Carbone KM (1995). Boma disease virus and schizophrenia. Psychi-aby Res 56: 33–44.
  • Weisman Y, Huminer D, Malkinson M, Meir R, Kliche S, Lipkin WI, Pitlik S (1994). Boma disease virus antibod-ies among workers exposed to infected ostriches [letter]. Lancet 344: 1232–1233.
  • Weissenböck H, Hornig M, Hickey WF, Lipkin WI (2000). Microglial activation and neuronal apoptosis in Bornavirus infected neonatal Lewis rats. Brain Pathol 10: 260–272.
  • Weissenbock H, Nowotny N, Caplazi P, Kolodziejek J, Ehrensperger F (1998). Boma disease in a dog with lethal meningoencephalitis. J Clin Microbic)] 36: 2127–2130.
  • Wittrup IH, Christensen LS, Jensen B, Danneskiold-Samsee B, Bliddal H, Wiik A (2000). Search for Borna disease virus in Danish fibromyalgia patients. Scand J Rheuma-tol 29: 387–390.
  • Wolff T, Unterstab G, Heins G, Richt JA, Kann M (2002). Characterization of an unusual importin alpha binding motif in the borna disease virus p10 protein that directs nuclear import. J Biol Chem 277: 12151–12157.
  • Yamaguchi K, Sawada T, Naraki T, Igata-Yi R, Shiraki H, Horii Y, Ishii T, Ikeda K, Asou N, Okabe H, Mochizuki M, Takahashi K, Yamada S, Kubo K, Yashiki S, Waltrip RW, 2nd, Carbone KM (1999). Detection of borna dis-ease virus-reactive antibodies from patients with psy-chiatric disorders and from horses by electrochemilu-minescence immunoassay. Clin Diagn Lab Immunol 6: 696–700.
  • Yilmaz H, Helps CR, Turan N, Uysal A, Harbour DA (2002). Detection of antibodies to Boma disease virus (BDV) in Turkish horse sera using recombinant p40. Brief report. Arch Virol 147: 429–435.
  • Zimmermann W, Durrwald R, Ludwig H (1994). Detection of Boma disease virus RNA in naturally infected animals by a nested polymerase chain reaction. J Virol Methods 46: 133–143.
  • Zocher M, Czub S, Schulte-Monting J, de La Torre JC, Sauder C (2000). Alterations in neurotrophin and neu-rotrophin receptor gene expression patterns in the rat central nervous system following perinatal Boma dis-ease virus infection. J NeuroVirol 6: 462–477.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.